Works matching DE "GLUCAGON-like peptide-1 agonists"
Results: 2590
Effects of GLP‐1 Receptor Agonists in Alcohol Use Disorder.
- Published in:
- Basic & Clinical Pharmacology & Toxicology, 2025, v. 136, n. 3, p. 1, doi. 10.1111/bcpt.70004
- By:
- Publication type:
- Article
Brown Adipose Tissue Mimicking Head and Neck Cancer on PET Scan in a Patient on GLP‐1 Drug.
- Published in:
- Laryngoscope, 2025, v. 135, n. 2, p. 741, doi. 10.1002/lary.31815
- By:
- Publication type:
- Article
Is Weight Loss the Main Driver for A1C Improvement by Glucagon‐Like Peptide 1 (GLP‐1) Receptor Agonists? A 2.5‐Year Analysis in Real‐World Clinical Practice.
- Published in:
- Journal of Diabetes, 2025, v. 17, n. 1, p. 1, doi. 10.1111/1753-0407.70054
- By:
- Publication type:
- Article
Cardiovascular Therapy Benefits of Novel Antidiabetic Drugs in Patients With Type 2 Diabetes Mellitus Complicated With Cardiovascular Disease: A Network Meta‐Analysis.
- Published in:
- Journal of Diabetes, 2025, v. 17, n. 1, p. 1, doi. 10.1111/1753-0407.70044
- By:
- Publication type:
- Article
SGLT2i and GLP1RA effects in patients followed in a hospital diabetology consultation.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 11, p. 1081, doi. 10.1080/17512433.2024.2421872
- By:
- Publication type:
- Article
Semaglutide and smoking cessation in individuals with type 2 diabetes mellitus: there is no smoke without fire!
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 11, p. 1009, doi. 10.1080/17512433.2024.2418398
- By:
- Publication type:
- Article
Lipid profile changes induced by glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 8, p. 721, doi. 10.1080/17512433.2024.2363838
- By:
- Publication type:
- Article
Revolutionizing diabetes care: unveiling tirzepatide's potential in glycemic control and beyond.
- Published in:
- Expert Review of Clinical Pharmacology, 2024, v. 17, n. 3, p. 235, doi. 10.1080/17512433.2024.2310070
- By:
- Publication type:
- Article
Effect of the glucagon‐like peptide‐1 receptor agonists on diabetic peripheral neuropathy: A meta‐analysis.
- Published in:
- Journal of Neurochemistry, 2025, v. 169, n. 2, p. 1, doi. 10.1111/jnc.16242
- By:
- Publication type:
- Article
Association between glucagon-like peptide-1 agonists and risk of diabetic retinopathy: a disproportionality analysis using FDA adverse event reporting system data.
- Published in:
- Expert Review of Endocrinology & Metabolism, 2025, v. 20, n. 2, p. 147, doi. 10.1080/17446651.2025.2459720
- By:
- Publication type:
- Article
The vascular complications of diabetes: a review of their management, pathogenesis, and prevention.
- Published in:
- Expert Review of Endocrinology & Metabolism, 2024, v. 19, n. 1, p. 11, doi. 10.1080/17446651.2023.2279533
- By:
- Publication type:
- Article
Age and outcomes in people with type 2 diabetes admitted to hospital with COVID‐19: A cohort study.
- Published in:
- Diabetic Medicine, 2025, v. 42, n. 4, p. 1, doi. 10.1111/dme.15481
- By:
- Publication type:
- Article
Impact of glucagon‐like peptide‐1 receptor agonists on diabetic retinopathy: A meta‐analysis of clinical studies emphasising retinal changes as a primary outcome.
- Published in:
- Clinical & Experimental Ophthalmology, 2025, v. 53, n. 1, p. 67, doi. 10.1111/ceo.14445
- By:
- Publication type:
- Article
Addressing inequality of health care.
- Published in:
- Medical Journal of Australia, 2025, v. 222, n. 3, p. 109, doi. 10.5694/mja2.52601
- By:
- Publication type:
- Article
The role of GLP‐1 receptor agonists in the management of obesity: risks and opportunities for the Australian health care system.
- Published in:
- Medical Journal of Australia, 2025, v. 222, n. 3, p. 118, doi. 10.5694/mja2.52582
- By:
- Publication type:
- Article
The role of GLP‐1 receptor agonists in the management of obesity: risks and opportunities for the Australian health care system.
- Published in:
- Medical Journal of Australia, 2025, v. 222, n. 2, p. 118, doi. 10.5694/mja2.52582
- By:
- Publication type:
- Article
Addressing inequality of health care.
- Published in:
- Medical Journal of Australia, 2025, v. 222, n. 2, p. 109, doi. 10.5694/mja2.52601
- By:
- Publication type:
- Article
A special issue on from bench to bedside: An integrated and multidisciplinary approach to tackling diabetic kidney disease.
- Published in:
- Diabetic Medicine, 2025, v. 42, n. 2, p. 1, doi. 10.1111/dme.15501
- By:
- Publication type:
- Article
Current management of chronic kidney disease in type‐2 diabetes—A tiered approach: An overview of the joint Association of British Clinical Diabetologists and UK Kidney Association (ABCD‐UKKA) guidelines.
- Published in:
- Diabetic Medicine, 2025, v. 42, n. 2, p. 1, doi. 10.1111/dme.15450
- By:
- Publication type:
- Article
Pharmacological treatment options for metabolic dysfunction‐associated steatotic liver disease in patients with type 2 diabetes mellitus: A systematic review.
- Published in:
- European Journal of Clinical Investigation, 2025, v. 54, n. 11, p. 1, doi. 10.1111/eci.70003
- By:
- Publication type:
- Article
GLP‐1 receptor agonists and retained gastric content: Is it much ado about nothing?
- Published in:
- Obesity (19307381), 2025, v. 33, n. 2, p. 221, doi. 10.1002/oby.24215
- By:
- Publication type:
- Article
Glucagon‐like peptide‐1 receptor agonists and upper endoscopy: a real‐world experience.
- Published in:
- Obesity (19307381), 2025, v. 33, n. 2, p. 250, doi. 10.1002/oby.24190
- By:
- Publication type:
- Article
GLP1Ra‐based therapies and DXA‐acquired musculoskeletal health outcomes: a focused meta‐analysis of placebo‐controlled trials.
- Published in:
- Obesity (19307381), 2025, v. 33, n. 2, p. 225, doi. 10.1002/oby.24172
- By:
- Publication type:
- Article
Liraglutide Treatment Improves Glycaemic Dysregulation, Body Composition, Cardiometabolic Variables and Uncontrolled Eating Behaviour in Adolescents with Severe Obesity.
- Published in:
- Journal of Clinical Research in Pediatric Endocrinology, 2025, v. 17, n. 1, p. 68, doi. 10.4274/jcrpe.galenos.2024.2023-10-10
- By:
- Publication type:
- Article
Gastric point‐of‐care ultrasound in the GLP‐1 receptor agonist era: clinical impact and competency.
- Published in:
- Anaesthesia, 2025, v. 80, n. 4, p. 362, doi. 10.1111/anae.16548
- By:
- Publication type:
- Article
Considerations on peri‐operative management of GLP‐1 receptor agonists.
- Published in:
- Anaesthesia, 2025, v. 80, n. 3, p. 340, doi. 10.1111/anae.16524
- By:
- Publication type:
- Article
Routine peri‐operative cessation of glucagon‐like peptide‐1 receptor agonists has unintended consequences.
- Published in:
- Anaesthesia, 2025, v. 80, n. 3, p. 339, doi. 10.1111/anae.16509
- By:
- Publication type:
- Article
Residual gastric content and peri‐operative semaglutide use assessed by gastric ultrasound.
- Published in:
- Anaesthesia, 2025, v. 80, n. 3, p. 338, doi. 10.1111/anae.16504
- By:
- Publication type:
- Article
The hidden impact of GLP‐1 receptor agonists on endometrial receptivity and implantation.
- Published in:
- Acta Obstetricia et Gynecologica Scandinavica, 2025, v. 104, n. 2, p. 258, doi. 10.1111/aogs.15010
- By:
- Publication type:
- Article
Navigating the Landscape of Diabetes Medications: A Comprehensive Guide.
- Published in:
- African Journal of Diabetes Medicine, 2024, v. 32, n. 2, p. 1, doi. 10.54931/AJDM-32.2.15
- By:
- Publication type:
- Article
Different strokes for different folks? How the latest US standards of diabetes care could impact UK practice.
- Published in:
- Practice Nurse, 2025, v. 55, n. 2, p. 26
- By:
- Publication type:
- Article
Commentary on Qeadan et al.: Leveraging opportunities to expand the substance use disorder treatment arsenal.
- Published in:
- Addiction, 2025, v. 120, n. 2, p. 251, doi. 10.1111/add.16725
- By:
- Publication type:
- Article
The association between glucose‐dependent insulinotropic polypeptide and/or glucagon‐like peptide‐1 receptor agonist prescriptions and substance‐related outcomes in patients with opioid and alcohol use disorders: A real‐world data analysis
- Published in:
- Addiction, 2025, v. 120, n. 2, p. 236, doi. 10.1111/add.16679
- By:
- Publication type:
- Article
GLP‐1R agonist medications for addiction treatment.
- Published in:
- 2025
- By:
- Publication type:
- Editorial
Exploring the hair loss risk in glucagon‐like peptide‐1 agonists: Emerging concerns and clinical implications.
- Published in:
- Journal of the European Academy of Dermatology & Venereology, 2025, v. 39, n. 2, p. 263, doi. 10.1111/jdv.20512
- By:
- Publication type:
- Article
The potential role of GLP‐1 receptor agonists in osteoarthritis.
- Published in:
- Pharmacotherapy, 2025, v. 45, n. 3, p. 177, doi. 10.1002/phar.70005
- By:
- Publication type:
- Article
Enhanced FGF21 Delivery via Neutrophil-Membrane-Coated Nanoparticles Improves Therapeutic Efficacy for Myocardial Ischemia–Reperfusion Injury.
- Published in:
- Nanomaterials (2079-4991), 2025, v. 15, n. 5, p. 346, doi. 10.3390/nano15050346
- By:
- Publication type:
- Article
Insights into the Roles of GLP-1, DPP-4, and SGLT2 at the Crossroads of Cardiovascular, Renal, and Metabolic Pathophysiology.
- Published in:
- Cells (2073-4409), 2025, v. 14, n. 5, p. 387, doi. 10.3390/cells14050387
- By:
- Publication type:
- Article
Improvement in Helicobacter pylori Eradication Among Adults Receiving Semaglutide: A Population‐Based Propensity‐Score‐Adjusted Analysis.
- Published in:
- Helicobacter, 2025, v. 30, n. 1, p. 1, doi. 10.1111/hel.70014
- By:
- Publication type:
- Article
The Utility of a Digital Glucose‐Like Peptide‐1 Receptor Agonist‐Supported Weight‐Loss Service in Regional Australia: A Qualitative Analysis of Interviews With Current Patients of the Eucalyptus Program.
- Published in:
- Australian Journal of Rural Health, 2025, v. 33, n. 1, p. 1, doi. 10.1111/ajr.13220
- By:
- Publication type:
- Article
Correction: Glucagon-like peptide-1 receptor agonists (GLP-1RAs) and cardiometabolic protection: historical development and future challenges.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
RE: Glucagon-like peptide 1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 562, doi. 10.1093/jnci/djae324
- By:
- Publication type:
- Article
Glucagon-like peptide-1 receptor agonists and pancreatic cancer risk: target trial emulation using real-world data.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2025, v. 117, n. 3, p. 476, doi. 10.1093/jnci/djae260
- By:
- Publication type:
- Article
What's hot in diabetes nursing? February 2025.
- Published in:
- Journal of Diabetes Nursing, 2025, v. 29, n. 1, p. 1
- Publication type:
- Article
Latest news: GLP-1 agonists safety update, and National Diabetes Experience Survey results.
- Published in:
- Journal of Diabetes Nursing, 2025, v. 29, n. 1, p. 1
- Publication type:
- Article
Beyond Diabetes: Semaglutide's Role in Modulating Mood Disorders through Neuroinflammation Pathways.
- Published in:
- Cellular & Molecular Neurobiology, 2025, v. 45, n. 1, p. 1, doi. 10.1007/s10571-025-01534-4
- By:
- Publication type:
- Article
Les agonistes au récepteur du GLP-1 réduisent-ils vraiment l'incidence des complications hépatiques chez les diabétiques de type 2 ayant une maladie chronique du foie ?
- Published in:
- Hépato-Gastro & Oncologie Digestive, 2025, v. 32, n. 2, p. 208, doi. 10.1684/hpg.2025.2915
- By:
- Publication type:
- Article
Potential benefits of GLP-1 receptor agonist in dialysis patients with type 2 diabetes: the need for comprehensive pharmacokinetic and hemodialysis analyses.
- Published in:
- Cardiovascular Diabetology, 2025, v. 24, n. 1, p. 1, doi. 10.1186/s12933-024-02543-1
- By:
- Publication type:
- Article
Hematologic Cancers Among Patients With Type 2 Diabetes Prescribed GLP-1 Receptor Agonists.
- Published in:
- JAMA Network Open, 2025, v. 8, n. 3, p. e250802, doi. 10.1001/jamanetworkopen.2025.0802
- By:
- Publication type:
- Article
Postoperative Aspiration Pneumonia Among Adults Using GLP-1 Receptor Agonists.
- Published in:
- JAMA Network Open, 2025, v. 8, n. 3, p. e250081, doi. 10.1001/jamanetworkopen.2025.0081
- By:
- Publication type:
- Article